StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $115 at Evercore ISI
August 6, 2024 5:02 AM
Evercore ISI analyst Cory Kasimov raised the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $115.00 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $110 at Barclays
August 6, 2024 3:01 AM
Form 10-Q BIOMARIN PHARMACEUTICAL For: Jun 30
August 5, 2024 4:36 PM
BioMarin Pharma (BMRN) Tops Q2 EPS by 61c ; Offers Guidance
August 5, 2024 4:06 PM
Form 8-K BIOMARIN PHARMACEUTICAL For: Aug 05
August 5, 2024 4:06 PM
BioMarin Announces 20% Y/Y Total Revenue Growth in the Second Quarter and Increase in Full-year 2024 Guidance
August 5, 2024 4:03 PM
BioMarin Pharma (BMRN) Announces Updated Strategy for ROCTAVIAN to Focus on U.S., Germany and Italy
August 5, 2024 4:01 PM
BioMarin Announces Updated Strategy for ROCTAVIAN® to Focus on U.S., Germany and Italy
August 5, 2024 4:01 PM
